Last week, Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their … [Read More...] about The biggest diabetes tech news out of ATTD 2025
Main Content
Sponsored Content
Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts
SiBionics unveils ‘world’s thinnest’ CGM, earns CE mark
SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval. The company unveiled the device — which it touts as the world's thinnest CGM — at last week's 18th International Conference on … [Read More...] about SiBionics unveils ‘world’s thinnest’ CGM, earns CE mark
Dexcom picks longtime Masimo exec as next CCO
Dexcom (Nasdaq:DXCM) announced today that it appointed Jon Coleman as its new chief commercial officer (CCO). Coleman assumes responsibility for Dexcom's global commercial organization, including global sales, marketing and customer experience. He … [Read More...] about Dexcom picks longtime Masimo exec as next CCO
Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’
Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company's first quarterly … [Read More...] about Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’
Nanowear enters CGM licensing, data partnership with Dexcom
Nanowear announced today that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose monitors (CGMs). The partnership will see Nanowear's SimpleSense nanotechnology-enabled wearable, mobile and software … [Read More...] about Nanowear enters CGM licensing, data partnership with Dexcom
Enable Injections wins CE mark for enFuse drug delivery device
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery. enFuse, an on-body delivery system, provides subcutaneous abdominal bolus administration of drug or biologic products in … [Read More...] about Enable Injections wins CE mark for enFuse drug delivery device
The biggest diabetes tech news out of ATTD 2025
Last week, Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their … [Read More...] about The biggest diabetes tech news out of ATTD 2025
Beta Bionics founder talks bringing ‘bionic pancreas’ to market
Around 25 years ago, Ed Damiano’s 11-month-old son developed type 1 diabetes. Damiano, a professor of mechanical engineering, made it his goal to make it easier to manage his young son’s condition. Speaking on a panel at the MassMedic 2025 … [Read More...] about Beta Bionics founder talks bringing ‘bionic pancreas’ to market
Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Of the hundreds of millions of people living with diabetes, the vast majority live with type 2. Dexcom (Nasdaq:DXCM) wants to make sure they have the tools to manage that. The International Diabetes Federation says that more than 90% of people … [Read More...] about Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Modular Medical announces $12M private placement
Modular Medical (Nasdaq:MODD) announced today that it entered into definitive subscription agreements worth proceeds of approximately $12 million. The insulin patch pump maker company entered the agreements with institutional and accredited … [Read More...] about Modular Medical announces $12M private placement
Medtronic reports first real-world data on smart insulin pen system
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic's Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor … [Read More...] about Medtronic reports first real-world data on smart insulin pen system
In case you missed it
- Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
- Tandem has positive data for automated insulin delivery in type 2 diabetes population
- Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
- Dexcom study finds that providers prefer tech over medication for type 2 diabetes
- Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
- Ypsomed, CamDiab launch iOS app for automated insulin delivery system
- Insulet CTO Mark Field departs for new opportunities
- Insulet expands Omnipod 5 to more countries, prices $450M offering
- Sequel Med Tech makes first CGM integration with Abbott for automated insulin pump
- Vivani reports first human GLP-1 implant for weight loss in adults
- Trinity Biotech to undergo strategic realignment, focus on CGM development
- Vivani to spin out neurostim business, focus on GLP-1 implant
- Dexcom receives FDA warning letter
- Real-world data backs Insulet Omnipod 5 in children
- Baxter warns on certain infusion pumps with missing screws
Clinical Trials
The biggest diabetes tech news out of ATTD 2025
Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]
Medtronic reports first real-world data on smart insulin pen system
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic’s Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor (CGM). Data showed how the system, designed for people with diabetes using multiple daily injections (MDI) when used as intended, […]
Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Insulet (Nasdaq:PODD) today announced new Omnipod 5 clinical data highlighting the transition from multiple daily injections (MDI). Investigators shared data from the RADIANT study at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam. The randomized controlled trial evaluated the direct transition from MDI to automated insulin delivery (AID). Insulet […]
Tandem has positive data for automated insulin delivery in type 2 diabetes population
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for type 2 diabetes. San Diego-based Tandem won FDA clearance for its Control-IQ+ next-generation algorithm for type 2 diabetes at the end of last month. Just yesterday, the company announced the launch of the algorithm. Control-IQ+ represents the next generation of the […]
Vivani reports first human GLP-1 implant for weight loss in adults
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 clinical trial. This news comes just one day after Vivani announced plans to spin off its neurostimulation business to focus on its GLP-1 implants. The company also announced full enrollment in LIBERATE-1, achieved in just four weeks after the […]
